In vivo assay on NSCLC-bearing mice showed that calotropin treatment markedly inhibited tumor growth, increased the number of apoptotic cells, and significantly promoted apoptosis markers: caspase-3 and caspase-8. This evidence concerns the gene CASP3 and non-small cell lung carcinoma.